Use access key #2 to skip to page content.
$71.38 0.10 (0.14%)
7/23/2008 4:00 PM

Biogen Idec, Inc. (BIIB)

CAPS Rating:
****

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies.

View All Commentary (BIIB)

Recs

0

Avatar LeBella (36.02) Submitted: 3/14/08 4:15 PM : Outperform Start Price: $60.33 BIIB Score: 19.20

Biotech firm, medical good investment

Report this Post Replies: 1 | Reply

Avatar iambligh (< 20) Submitted: 4/06/08 10:48 AM

Recs: 0 | Rec This

I agree.

Report this Post Reply

Featured Broker Partners